{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute%2C+Uncomplicated+Human+Influenza", "query": { "condition": "Acute, Uncomplicated Human Influenza" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 16, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute%2C+Uncomplicated+Human+Influenza&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-29T10:43:08.513Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04610047", "title": "Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza", "Influenza -Like Illness" ], "interventions": [ { "name": "Norketotifen", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emergo Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 315, "start_date": "2020-12-14", "completion_date": "2022-02-09", "has_results": false, "last_update_posted_date": "2023-01-30", "last_synced_at": "2026-09-29T10:43:08.513Z", "location_count": 20, "location_summary": "Phoenix, Arizona • Los Angeles, California • DeBary, Florida + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "DeBary", "state": "Florida" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04610047" }, { "nct_id": "NCT00419263", "title": "Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Peramivir 150 mg", "type": "DRUG" }, { "name": "Peramivir 300 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioCryst Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 344, "start_date": "2007-01", "completion_date": "2007-09", "has_results": true, "last_update_posted_date": "2015-02-12", "last_synced_at": "2026-09-29T10:43:08.513Z", "location_count": 58, "location_summary": "Birmingham, Alabama • Jonesboro, Arkansas • Anaheim, California + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" }, { "city": "Carmichael", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00419263" }, { "nct_id": "NCT00705406", "title": "A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute, Uncomplicated Human Influenza" ], "interventions": [ { "name": "Peramivir", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioCryst Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 405, "start_date": "2008-07", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2015-02-16", "last_synced_at": "2026-09-29T10:43:08.513Z", "location_count": 67, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Jonesboro, Arkansas + 58 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00705406" }, { "nct_id": "NCT01610245", "title": "Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Nitazoxanide", "type": "DRUG" }, { "name": "Oseltamivir", "type": "DRUG" }, { "name": "Placebo Oral Tablet", "type": "DRUG" }, { "name": "Placebo Oral Capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Romark Laboratories L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "13 Years to 65 Years" }, "enrollment_count": 1941, "start_date": "2013-03", "completion_date": "2015-04-16", "has_results": false, "last_update_posted_date": "2018-03-29", "last_synced_at": "2026-09-29T10:43:08.513Z", "location_count": 136, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Hoover, Alabama + 121 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01610245" }, { "nct_id": "NCT02623322", "title": "A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza A" ], "interventions": [ { "name": "MHAA4549A", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 124, "start_date": "2016-10-12", "completion_date": "2017-11-13", "has_results": true, "last_update_posted_date": "2019-01-08", "last_synced_at": "2026-09-29T10:43:08.513Z", "location_count": 38, "location_summary": "Athens, Alabama • Costa Mesa, California • Fountain Valley, California + 32 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "Doral", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02623322" }, { "nct_id": "NCT02612922", "title": "Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Nitazoxanide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Romark Laboratories L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 325, "start_date": "2015-12", "completion_date": "2016-09-04", "has_results": false, "last_update_posted_date": "2018-04-04", "last_synced_at": "2026-09-29T10:43:08.513Z", "location_count": 17, "location_summary": "Hot Springs, Arkansas • Anaheim, California • Fresno, California + 14 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Lomita", "state": "California" }, { "city": "Kissimmee", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02612922" }, { "nct_id": "NCT02469298", "title": "Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Virus Diseases" ], "interventions": [ { "name": "GSK1325756 (Danirixin)", "type": "DRUG" }, { "name": "Placebo To Match GSK1325756", "type": "DRUG" }, { "name": "Oseltamivir Phosphate", "type": "DRUG" }, { "name": "Placebo To Match Oseltamivir Phosphate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 45, "start_date": "2015-06-01", "completion_date": "2016-04-25", "has_results": true, "last_update_posted_date": "2019-07-23", "last_synced_at": "2026-09-29T10:43:08.513Z", "location_count": 5, "location_summary": "Palmetto Bay, Florida • Blackfoot, Idaho • Oklahoma City, Oklahoma + 2 more", "locations": [ { "city": "Palmetto Bay", "state": "Florida" }, { "city": "Blackfoot", "state": "Idaho" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Medford", "state": "Oregon" }, { "city": "Marshfield", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02469298" }, { "nct_id": "NCT00610935", "title": "Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Peramivir", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioCryst Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 82, "start_date": "2008-01", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2021-03-17", "last_synced_at": "2026-09-29T10:43:08.513Z", "location_count": 96, "location_summary": "Millbrook, Alabama • Tuscaloosa, Alabama • Phoenix, Arizona + 80 more", "locations": [ { "city": "Millbrook", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00610935" }, { "nct_id": "NCT01056380", "title": "Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Nitazoxanide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Romark Laboratories L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 79, "start_date": "2010-01", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2018-04-05", "last_synced_at": "2026-09-29T10:43:08.513Z", "location_count": 1, "location_summary": "Elmira, New York", "locations": [ { "city": "Elmira", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01056380" }, { "nct_id": "NCT02867358", "title": "A Clinical Trial of KT07 Capsule in the U.S.A", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "KT07 Capsule", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Yiling Pharmaceutical Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 391, "start_date": "2016-09", "completion_date": "2020-07-31", "has_results": false, "last_update_posted_date": "2020-08-31", "last_synced_at": "2026-09-29T10:43:08.513Z", "location_count": 81, "location_summary": "Birmingham, Alabama • Pelham, Alabama • Tolleson, Arizona + 66 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Pelham", "state": "Alabama" }, { "city": "Tolleson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02867358" } ] }